3 results
8-K
EX-99.2
MIRM
Mirum Pharmaceuticals Inc
8 Jan 24
Mirum Pharmaceuticals Announces Preliminary Unaudited 2023 Net Revenue and Provides Corporate Updates
8:30am
presented at: European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN): Annual Meeting; June 22-25, 2022; Copenhagen, Denmark … in patients with Alagille syndrome treated with maralixibat, an IBAT inhibitor. Paper presented at: European Society for Paediatric Gastroenterology
8-K
EX-99.1
MIRM
Mirum Pharmaceuticals Inc
2 Nov 23
Results of Operations and Financial Condition
4:06pm
at the North American Society for Pediatric, Gastroenterology, Hepatology and Nutrition (NASPGHAN) Annual Meeting.
Supplemental New Drug Application (sNDA
8-K
EX-99.1
MIRM
Mirum Pharmaceuticals Inc
6 May 21
Mirum Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Business Update
4:06pm
accepted for presentation at the American Society of Gene and Cell Therapy Annual Meeting in May 2021.
Business Update Conference Call
Mirum
- Prev
- 1
- Next